Terms: = Bone cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL
219 results:
1. Donor
Schetelig J; Baldauf H; Heidenreich F; Hoogenboom JD; Spellman SR; Kulagin A; Schroeder T; Sengeloev H; Dreger P; Forcade E; Vydra J; Wagner-Drouet EM; Choi G; Paneesha S; Miranda NAA; Tanase A; de Wreede LC; Lange V; Schmidt AH; Sauter J; Fein JA; Bolon YT; He M; Marsh SGE; Gadalla SM; Paczesny S; Ruggeri A; Chabannon C; Fleischhauer K
Front Immunol; 2024; 15():1350470. PubMed ID: 38629074
[TBL] [Abstract] [Full Text] [Related]
2. Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.
Trottier AM; Feurstein S; Godley LA
Best Pract Res Clin Haematol; 2024 Mar; 37(1):101537. PubMed ID: 38490765
[TBL] [Abstract] [Full Text] [Related]
3. Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome.
Arai H; Matsui H; Chi S; Utsu Y; Masuda S; Aotsuka N; Minami Y
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203823
[TBL] [Abstract] [Full Text] [Related]
4. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-abl1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of novel mutations in the tel-patch domain of the telomeric factor TPP1 associated with telomere biology disorders.
Bertrand A; Ba I; Kermasson L; Pirabakaran V; Chable N; Lainey E; Ménard C; Kallel F; Picard C; Hadiji S; Coolen-Allou N; Blanchard E; de Villartay JP; Moshous D; Roelens M; Callebaut I; Kannengiesser C; Revy P
Hum Mol Genet; 2024 Mar; 33(7):612-623. PubMed ID: 38176734
[TBL] [Abstract] [Full Text] [Related]
6. Genetic Characterization of Pediatric Mixed Phenotype Acute Leukemia (MPAL).
Panagopoulos I; Andersen K; Johannsdottir IMR; Tandsæther MR; Micci F; Heim S
Cancer Genomics Proteomics; 2024; 21(1):1-11. PubMed ID: 38151288
[TBL] [Abstract] [Full Text] [Related]
7. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases.
Saft L; Kvasnicka HM; Boudova L; Gianelli U; Lazzi S; Rozman M
Histopathology; 2023 Dec; 83(6):829-849. PubMed ID: 37551450
[TBL] [Abstract] [Full Text] [Related]
8. Myeloproliferative Neoplasm Driven by
Renzi S; Algawahmed F; Davidson S; Langenberg KPS; Fuligni F; Ali S; Anderson N; Brunga L; Bartram J; Abdelhaleem M; Naqvi A; Beimnet K; Schuh A; Tierens A; Malkin D; Shlien A; Shago M; Villani A
Curr Oncol; 2023 Jun; 30(7):5946-5952. PubMed ID: 37503586
[No Abstract] [Full Text] [Related]
9. Marginal resection as a potential curative treatment option of infantile fibrosarcoma with good response after chemotherapy: A case report of an etv6-NTRK3 positive infantile fibrosacroma of the distal tibia.
Weber M; von Kunow F; Hillmann A
Medicine (Baltimore); 2023 Jul; 102(27):e34194. PubMed ID: 37417635
[TBL] [Abstract] [Full Text] [Related]
10. The international consensus classification of eosinophilic disorders and systemic mastocytosis.
Wang SA; Orazi A; Gotlib J; Reiter A; Tzankov A; Hasserjian RP; Arber DA; Tefferi A
Am J Hematol; 2023 Aug; 98(8):1286-1306. PubMed ID: 37283522
[TBL] [Abstract] [Full Text] [Related]
11. The KMT2A recombinome of acute leukemias in 2023.
Meyer C; Larghero P; Almeida Lopes B; Burmeister T; Gröger D; Sutton R; Venn NC; Cazzaniga G; Corral Abascal L; Tsaur G; Fechina L; Emerenciano M; Pombo-de-Oliveira MS; Lund-Aho T; Lundán T; Montonen M; Juvonen V; Zuna J; Trka J; Ballerini P; Lapillonne H; Van der Velden VHJ; Sonneveld E; Delabesse E; de Matos RRC; Silva MLM; Bomken S; Katsibardi K; Keernik M; Grardel N; Mason J; Price R; Kim J; Eckert C; Lo Nigro L; Bueno C; Menendez P; Zur Stadt U; Gameiro P; Sedék L; Szczepański T; Bidet A; Marcu V; Shichrur K; Izraeli S; Madsen HO; Schäfer BW; Kubetzko S; Kim R; Clappier E; Trautmann H; Brüggemann M; Archer P; Hancock J; Alten J; Möricke A; Stanulla M; Lentes J; Bergmann AK; Strehl S; Köhrer S; Nebral K; Dworzak MN; Haas OA; Arfeuille C; Caye-Eude A; Cavé H; Marschalek R
Leukemia; 2023 May; 37(5):988-1005. PubMed ID: 37019990
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.
Zhang L; Shah B; Zhang Y; Tashkandi H; Xiao W; Fernandez-Pol S; Vergara-Lluri M; Hussaini M; Song J; Lancet J; Moscinski L; Yun S; Lu CM; Medeiros LJ; Tang G
Hum Pathol; 2023 Jun; 136():1-15. PubMed ID: 36958463
[TBL] [Abstract] [Full Text] [Related]
13. Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT).
Clark A; Thomas S; Hamblin A; Talley P; Kulasekararaj A; Grinfeld J; Speight B; Snape K; McVeigh TP; Snowden JA
Br J Haematol; 2023 Apr; 201(1):35-44. PubMed ID: 36786081
[TBL] [Abstract] [Full Text] [Related]
14. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
[TBL] [Abstract] [Full Text] [Related]
15. High frequency of heat shock protein 27 overexpression is a highly effective, high-coverage marker for minimal residual disease detection in children with B-cell acute lymphoblastic leukemia.
Chou SW; Su YH; Lu MY; Chang HH; Yang YL; Lin DT; Lin KH; Coustan-Smith E; Jou ST
Pediatr Blood Cancer; 2023 Jan; 70(1):e29990. PubMed ID: 36250996
[TBL] [Abstract] [Full Text] [Related]
16. Updates on eosinophilic disorders.
Tzankov A; Reichard KK; Hasserjian RP; Arber DA; Orazi A; Wang SA
Virchows Arch; 2023 Jan; 482(1):85-97. PubMed ID: 36068374
[TBL] [Abstract] [Full Text] [Related]
17. Germline etv6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitors.
Zhou C; Uluisik R; Rowley JW; David C; Jones CL; Scharer CD; Noetzli L; Fisher MH; Kirkpatrick GD; Bark K; Boss JM; Henry CJ; Pietras EM; Di Paola J; Porter CC
Exp Hematol; 2022; 112-113():24-34. PubMed ID: 35803545
[TBL] [Abstract] [Full Text] [Related]
18. GATA2 Deficiency in Adult Life Is Characterized by Phenotypic Diversity and Delayed Diagnosis.
Shamriz O; Zahalka N; Simon AJ; Lev A; Barel O; Mor N; Tal Y; Segel MJ; Somech R; Yonath H; Toker O
Front Immunol; 2022; 13():886117. PubMed ID: 35603181
[TBL] [Abstract] [Full Text] [Related]
19. Histologic characterization of paediatric mesenchymal neoplasms treated with kinase-targeted therapy.
Baranov E; Winsnes K; O'Brien M; Voss SD; Church AJ; Janeway KA; DuBois SG; Davis JL; Al-Ibraheemi A
Histopathology; 2022 Aug; 81(2):215-227. PubMed ID: 35543076
[TBL] [Abstract] [Full Text] [Related]
20. NTRK Fusions Detection in Paediatric Sarcomas to Expand the Morphological Spectrum and Clinical Relevance of Selected Entities.
Nozzoli F; Lazar AJ; Castiglione F; Campanacci DA; Beltrami G; De Logu F; Caporalini C; Massi D; Roviello G
Pathol Oncol Res; 2022; 28():1610237. PubMed ID: 35295613
[TBL] [Abstract] [Full Text] [Related]
[Next]
